Inflammation skews bone marrow hematopoiesis increasing the production of myeloid
effector cells at the expense of steady-state erythropoiesis. A compensatory stress …

Steady state erythropoiesis produces new erythrocytes at a constant rate to replace
senescent erythrocytes removed in the spleen and liver. Inflammation caused by infection or …

Infection and tissue damage induce inflammation, which increases myelopoiesis at the
expense of steady state erythropoiesis. Stress erythropoiesis is induced to compensate for …

Anemia of inflammation (AI) is the second most common anemia after iron-deficiency
anemia. It is often comorbid with other diseases such as infections, chronic kidney disease …

Inflammation alters hematopoiesis, skewing production to generate myeloid effector cells at
the expense of steady state erythropoiesis. To compensate, stress erythropoiesis is induced …

Anemia is a common secondary pathology resulting from inflammatory diseases including
cancer or infection. Its exact prevalence is difficult to determine, yet its contributions to the …

Anemic stress induces stress erythropoiesis, which rapidly generates new erythrocytes to
restore tissue oxygenation. Stress erythropoiesis is best understood in mice where it is …

Inflammation alters bone marrow hematopoiesis to favor the production of innate immune
effector cells at the expense of lymphoid cells and erythrocytes. Furthermore …

Anaemia occurs frequently in patients with heart failure and its current treatment lacks clear
targets. Emerging evidence suggests that erythroid progenitor cell expansion is an integral …

When steady-state erythropoiesis is inhibited, an extramedullary pathway called stress
erythropoiesis (SE) is initiated to maintain erythroid homeostasis and prevent potentially …